The role of megalin in secondary hyerparathyroidism of uremia
Project/Area Number |
24591235
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Kidney internal medicine
|
Research Institution | Osaka City University |
Principal Investigator |
IMANISHI Yasuo 大阪市立大学, 医学(系)研究科(研究院), 講師 (50326253)
|
Co-Investigator(Kenkyū-buntansha) |
YAMAGATA Masayo 大阪大谷大学, 薬学部, 講師 (50454583)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 副甲状腺メガリン / メガリン / 副甲状腺 / ビタミンD受容体 |
Outline of Final Research Achievements |
Megalin is a multiligand endocytotic receptor involving in the reabsorption of calcitriol and vitamin D binding protein in renal proximal tubules. Parathyroid glands also express megalin, however, little is known about its expressions and pathophysiological roles in hyperfunctioning parathyroid tumors. Its expression was observed in plasma membranes and cytoplasm in normal parathyroid glands. The expressions decreased in tumors with primary hyperparathyroidism and secondary hyperparathyroidism of uremia (SHPT) compared with strong expression in normal parathyroid glands. In SHPT, its expression was often particularly depressed in nodular areas, compared with adjacent diffuse hyperplasias. The reduced expression of both megalin and VDR may enhance vitamin D resistance and hyper-secretion of PTH from these tumors.
|
Report
(4 results)
Research Products
(26 results)
-
[Journal Article] Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis2015
Author(s)
Nagata, Y., Inaba, M., Imanishi, Y., Okazaki, H., Yamada, S., Mori, K., Shoji, S., Koyama, H. and Okuno, S
-
Journal Title
Osteoporos Int
Volume: 26
Issue: 3
Pages: 1053-61
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.2014
Author(s)
Ochi A, Mori K, Emoto M, Nakatani S, Morioka T, Motoyama K, Fukumoto S, Imanishi Y, Koyama H, Ishimura E, Inaba M
-
Journal Title
PLoS One
Volume: 9
Issue: 2
Pages: e88704-e88704
DOI
Related Report
Peer Reviewed
-
[Journal Article] Strategy of operative treatment of hyperparathyroidism using US scan and (99m)Tc-MIBI SPECT/CT2014
Author(s)
Noda S, Onoda N, Kashiwagi S, Kawajiri H, Takashima T, Ishikawa T, Yoshida A, Higashiyama S, Kawabe J, Imanishi Y, Tahara H, Inaba M, Osawa M, Hirakawa K
-
Journal Title
Endocr J
Volume: 61
Pages: 225-230
NAID
Related Report
Peer Reviewed
-
-
-
[Journal Article] Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.2012
Author(s)
Imanishi Y, Hashimoto J, Ando W, Kobayashi K, Ueda T, Nagata Y, Miyauchi A, Koyano HM, Kaji H, Saito T, Oba K, Komatsu Y, Morioka T, Mori K, Miki T, Inaba M
-
Journal Title
J Bone Miner Metab
Volume: 30
Issue: 1
Pages: 93-99
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-